Literature DB >> 18234060

BeWo trophoblast cell susceptibility to Toxoplasma gondii is increased by interferon-gamma, interleukin-10 and transforming growth factor-beta1.

B F Barbosa1, D A O Silva, I N Costa, J R Mineo, E A V Ferro.   

Abstract

The present study aimed to investigate BeWo trophoblast cell susceptibility to Toxoplasma gondii infection under stimulation with anti-inflammatory cytokines in comparison with HeLa cells. Both cell types were submitted to different treatments with recombinant cytokines [interleukin (IL)-10 and transforming growth factor (TGF)-beta1] or the respective antibodies (anti-IL-10 and anti-TGF-beta) before and after T. gondii infection. The effect of interferon (IFN)-gamma was also assessed alone or in combination with anti-inflammatory cytokines or the respective antibodies after the parasite infection. Cells were fixed, stained and parasites quantified under light microscopy to evaluate intracellular replication (mean number of parasites per cell in 100 infected cells) and infection index (percentage of infected cells per 100 examined cells). In contrast with HeLa cells, treatments with IL-10 or TGF-beta1 induced a considerable augmentation in both T. gondii intracellular replication and invasion into BeWo cells. In addition, treatment with IFN-gamma alone or associated with IL-10 or TGF-beta1 increased the same parameters in BeWo cells, whereas the opposite effect was observed in HeLa cells. When endogenous IL-10 or TGF-beta was blocked, both BeWo and HeLa cells were able to control the parasite infection only in the presence of IFN-gamma. Together, these results indicate that the higher susceptibility of BeWo cells to T. gondii may be due to immunomodulation mechanisms, suggesting that the role of trophoblast cells in maintaining a placental microenvironment favourable to pregnancy may facilitate the infection into the placental tissues.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18234060      PMCID: PMC2276970          DOI: 10.1111/j.1365-2249.2007.03583.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  42 in total

Review 1.  Cytokines during early pregnancy of mammals: a review.

Authors:  S Schäfer-Somi
Journal:  Anim Reprod Sci       Date:  2003-01-15       Impact factor: 2.145

2.  Infection of placental trophoblasts by Toxoplasma gondii.

Authors:  Marjan Abbasi; Kinga Kowalewska-Grochowska; Mohammad A Bahar; Ruhangiz T Kilani; Bonnie Winkler-Lowen; Larry J Guilbert
Journal:  J Infect Dis       Date:  2003-07-31       Impact factor: 5.226

3.  Oxidative killing of intracellular parasites mediated by macrophages.

Authors:  H P Hughes
Journal:  Parasitol Today       Date:  1988-12

4.  ICAM-1 is overexpressed by villous trophoblasts in placentitis.

Authors:  P B Juliano; M H S L Blotta; A M A Altemani
Journal:  Placenta       Date:  2006-01-10       Impact factor: 3.481

5.  Transforming growth factor-beta expression in human retinal pigment epithelial cells is enhanced by Toxoplasma gondii: a possible role in the immunopathogenesis of retinochoroiditis.

Authors:  C N Nagineni; B Detrick; J J Hooks
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

6.  Transforming growth factor-beta suppresses interferon-gamma-induced toxoplasmastatic activity in murine macrophages by inhibition of tumour necrosis factor-alpha production.

Authors:  J A Langermans; P H Nibbering; M E Van Vuren-Van Der Hulst; R Van Furth
Journal:  Parasite Immunol       Date:  2001-04       Impact factor: 2.280

Review 7.  Cytokine network at the feto-maternal interface.

Authors:  S Saito
Journal:  J Reprod Immunol       Date:  2000-07       Impact factor: 4.054

8.  Soluble factors from LPS- and PHA-activated PBMC induce MAPK, Stat1 and Stat3 phosphorylation in primary cultures of human term placental trophoblasts: implications for infection and prematurity.

Authors:  K Jiang; Y Chen; J N Jarvis
Journal:  Placenta       Date:  2006-08-10       Impact factor: 3.481

Review 9.  Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection.

Authors:  E Y Denkers; R T Gazzinelli
Journal:  Clin Microbiol Rev       Date:  1998-10       Impact factor: 26.132

10.  Human placental cytotrophoblasts produce the immunosuppressive cytokine interleukin 10.

Authors:  I Roth; D B Corry; R M Locksley; J S Abrams; M J Litton; S J Fisher
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

View more
  10 in total

1.  Tissue barriers of the human placenta to infection with Toxoplasma gondii.

Authors:  Jennifer R Robbins; Varvara B Zeldovich; Anna Poukchanski; John C Boothroyd; Anna I Bakardjiev
Journal:  Infect Immun       Date:  2011-11-14       Impact factor: 3.441

2.  IL-10 produced by trophoblast cells inhibits phagosome maturation leading to profound intracellular proliferation of Salmonella enterica Typhimurium.

Authors:  T Nguyen; N Robinson; S E Allison; B K Coombes; S Sad; L Krishnan
Journal:  Placenta       Date:  2013-07-05       Impact factor: 3.481

3.  Toxoplasma gondii activates hypoxia-inducible factor (HIF) by stabilizing the HIF-1alpha subunit via type I activin-like receptor kinase receptor signaling.

Authors:  Mandi Wiley; Kristin R Sweeney; Denise A Chan; Kevin M Brown; Curtis McMurtrey; Eric W Howard; Amato J Giaccia; Ira J Blader
Journal:  J Biol Chem       Date:  2010-06-25       Impact factor: 5.157

4.  IL-10 reduces levels of apoptosis in Toxoplasma gondii-infected trophoblasts.

Authors:  Mingdong Zhao; Ruijin Zhang; Xiaoyan Xu; Yang Liu; Haixia Zhang; Xiaoyu Zhai; Xuemei Hu
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

5.  Toxoplasma gondii migration within and infection of human retina.

Authors:  João M Furtado; Liam M Ashander; Kathleen Mohs; Timothy J Chipps; Binoy Appukuttan; Justine R Smith
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

6.  Regulation of pregnancy-associated plasma protein A2 (PAPPA2) in a human placental trophoblast cell line (BeWo).

Authors:  Pamela K Wagner; Aki Otomo; Julian K Christians
Journal:  Reprod Biol Endocrinol       Date:  2011-04-15       Impact factor: 5.211

7.  Enrofloxacin and Toltrazuril Are Able to Reduce Toxoplasma gondii Growth in Human BeWo Trophoblastic Cells and Villous Explants from Human Third Trimester Pregnancy.

Authors:  Rafaela J da Silva; Angelica O Gomes; Priscila S Franco; Ariane S Pereira; Iliana C B Milian; Mayara Ribeiro; Paolo Fiorenzani; Maria C Dos Santos; José R Mineo; Neide M da Silva; Eloisa A V Ferro; Bellisa de Freitas Barbosa
Journal:  Front Cell Infect Microbiol       Date:  2017-07-26       Impact factor: 5.293

8.  Increased Toxoplasma gondii Intracellular Proliferation in Human Extravillous Trophoblast Cells (HTR8/SVneo Line) Is Sequentially Triggered by MIF, ERK1/2, and COX-2.

Authors:  Iliana Claudia Balga Milian; Rafaela José Silva; Camilla Manzan-Martins; Bellisa Freitas Barbosa; Pamela Mendonça Guirelli; Mayara Ribeiro; Angelica de Oliveira Gomes; Francesca Ietta; José Roberto Mineo; Priscila Silva Franco; Eloisa Amália Vieira Ferro
Journal:  Front Microbiol       Date:  2019-04-24       Impact factor: 5.640

9.  Biogenic Silver Nanoparticles Can Control Toxoplasma gondii Infection in Both Human Trophoblast Cells and Villous Explants.

Authors:  Idessania Nazareth Costa; Mayara Ribeiro; Priscila Silva Franco; Rafaela José da Silva; Thádia Evelyn de Araújo; Iliana Claudia Balga Milián; Luana Carvalho Luz; Pâmela Mendonça Guirelli; Gerson Nakazato; José Roberto Mineo; Tiago W P Mineo; Bellisa Freitas Barbosa; Eloisa Amália Vieira Ferro
Journal:  Front Microbiol       Date:  2021-01-21       Impact factor: 5.640

10.  Cyclooxygenase (COX)-2 modulates Toxoplasma gondii infection, immune response and lipid droplets formation in human trophoblast cells and villous explants.

Authors:  Guilherme de Souza; Rafaela José Silva; Iliana Claudia Balga Milián; Alessandra Monteiro Rosini; Thádia Evelyn de Araújo; Samuel Cota Teixeira; Mário Cézar Oliveira; Priscila Silva Franco; Claudio Vieira da Silva; José Roberto Mineo; Neide Maria Silva; Eloisa Amália Vieira Ferro; Bellisa Freitas Barbosa
Journal:  Sci Rep       Date:  2021-06-16       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.